Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00326794
Other study ID # P011022
Secondary ID
Status Terminated
Phase Phase 3
First received May 15, 2006
Last updated May 15, 2006
Start date October 2002
Est. completion date September 2005

Study information

Verified date June 2005
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority France: Institutional Ethical Committee
Study type Interventional

Clinical Trial Summary

Background: Nonsurgical proximal humerus fracture is common, causing prolonged disability, for which the time to begin rehabilitation is not well determined. We assessed the feasibility and efficacy of early (within 3 days’after fracture) mobilisation of the shoulder compared with conventional 3-week immobilization followed by physiotherapy.


Description:

Methods: We randomly assigned 74 patients with impacted nonsurgically treated proximal humerus fracture to receive early passive mobilisation or conventional-treatment. The primary outcome was functional assessment of the shoulder (Constant score) at 3 months. Secondary outcomes were functional assessment at 6 weeks and at 6 months, change in pain (on a visual analogue scale) and passive range of motion.


Recruitment information / eligibility

Status Terminated
Enrollment 76
Est. completion date September 2005
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 20 Years and older
Eligibility Inclusion Criteria:

- Impacted nonsurgically treated proximal humerus fracture

- Patients over the age 20

Exclusion Criteria:

- Pre-existing shoulder pathology

- Neurological disorders of the upper limbs

- Indication for surgery of the shoulder

- Combined polytrauma

- Difficulties with language or comprehension to understand a rehabilitation program and information

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment


Intervention

Procedure:
mobilisation (rehabilitation)


Locations

Country Name City State
France Hopital Cochin Paris

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary The primary outcome was functional assessment of the shoulder (Constant score) at 3 months.
Secondary Functional assessment at 6 weeks and at 6 months
Secondary Change in pain (on a visual analogue scale)at 6 weeks, 3 months and at 6 months
Secondary Passive range of motion at 6 weeks, 3 months and at 6 months.
See also
  Status Clinical Trial Phase
Completed NCT02182752 - The Effect of Tramadol on Interscalene Brachial Plexus Block Phase 2